Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Membranous Nephropathy
  • Nephrotic Syndrome
Type
Interventional
Phase
Phase 1
Design
Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 79 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT04278729
Collaborators
American College of Clinical Pharmacy
Investigators
Principal Investigator: Daniel Crona, PharmD, PhD University of North Carolina, Chapel Hill